PwC: GLP-1 Use Drives Changes in Consumers’ Purchasing Decisions

GLP-1 adoption has more than doubled in 16 months, with 21% of U.S. households now including a current user (up from 9% in January 2025), according to the latest consumer trends data report from PwC (based on analysis of data from Numerator). The study also revealed how the use of the drug is reshaping purchasing habits across the board.